EquityZen Growth Technology Fund LLC - Series 2031
Raised
$166K
Investors
5
Min Invest
$14,938
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2031 is a Delaware-domiciled pooled investment fund filed by EquityZen Advisors LLC and Phil Haslett on 2024-12-30. The fund raised $166K from 5 investors under Rule 506(b) and 3(c)(1) exemptions, with a $15K minimum investment. It is part of the EquityZen platform, which operates 1,889 related pre-IPO investment vehicles.
This pre-IPO fund follows the standard EquityZen platform structure using 506(b) and 3(c)(1) exemptions with a retail-accessible $15K minimum. The capital raise and investor count are consistent with typical single-company series SPVs in the EquityZen family, targeting accredited individuals seeking fractional exposure to private growth companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.